Valuation Neuland Laboratories Limited NSE India S.E.

Stocks

Market Closed - NSE India S.E. 07:05:09 2026-10-06 EDT			5-day change	1st Jan Change
21,905.00 ^INR	+0.14%		+2.48%	+44.35%

09-15	Neuland Laboratories Limited Accelerates Peptide Manufacturing Expansion with Operational Module and Additional Capacity Expansion Underway	CI
09-07	Indian shares on track for muted open as oil climbs on rising Mideast risks	RE

Data adjusted to current consolidation scope

Fiscal Period: March	2022	2023	2024	2025	2026	2027	2028	2029
Market Cap ¹	13,171	23,087	80,588	154,946	154,121	280,867	-	-
Change	-	75.28%	249.07%	92.27%	-0.53%	82.24%	-	-
Enterprise Value (EV) ¹	13,171	23,087	80,374	153,929	153,584	283,429	281,847	278,571
Change	-	75.28%	248.14%	91.52%	-0.22%	84.54%	-0.56%	-1.16%
P/E	20.6x	14.1x	26.9x	-	42.3x	58.7x	45x	33.1x
PBR	1.58x	-	6.32x	10.2x	8.27x	12.2x	9.73x	7.78x
PEG	-	0x	0.3x	-	-	1.9x	1.5x	0.9x
Capitalization / Revenue	1.38x	1.94x	5.17x	10.5x	7.62x	11.5x	9.62x	8.04x
EV / Revenue	1.38x	1.94x	5.16x	10.4x	7.59x	11.6x	9.66x	7.98x
EV / EBITDA	9.24x	8.49x	17.4x	47.6x	26.7x	38.4x	29.8x	23.1x
EV / EBIT	14.1x	-	19.9x	59.7x	31.8x	44.2x	33.4x	26.4x
EV / FCF	-35.3x	13.5x	68.4x	139x	-304x	63.5x	69.7x	46.3x
FCF Yield	-2.83%	7.41%	1.46%	0.72%	-0.33%	1.58%	1.44%	2.16%
Dividend per Share ²	-	10	14	12	34	23.64	30.87	56.9
Rate of return	-	0.56%	0.22%	0.1%	0.28%	0.11%	0.14%	0.26%
EPS ²	49.74	127.4	233.9	-	283.7	372.7	486.5	661.4
Distribution rate	-	7.85%	5.99%	-	12%	6.34%	6.34%	8.6%
Net sales ¹	9,511	11,912	15,586	14,768	20,230	24,355	29,182	34,928
EBITDA ¹	1,426	2,718	4,626	3,233	5,745	7,381	9,452	12,056
EBIT ¹	935.8	-	4,029	2,577	4,828	6,409	8,437	10,566
Net income ¹	638.2	1,635	3,001	2,601	3,640	4,798	6,265	8,532
Net Debt ¹	-	-	-214.1	-1,017	-536.9	2,561	979.4	-2,296
Reference price ²	1,026.60	1,799.45	6,281.30	12,076.95	12,012.65	21,891.65	21,891.65	21,891.65
Nbr of stocks (in thousands)	12,830	12,830	12,830	12,830	12,830	12,830	-	-
Announcement Date	5/10/22	5/11/23	5/10/24	5/15/25	5/12/26	-	-	-

¹INR in Million²INR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ELI LILLY AND COMPANY	32.46x	11.79x	23.8x	0.61%	1,019B
JOHNSON & JOHNSON	28.13x	6.24x	17.86x	2.11%	610B
ABBVIE INC.	33.64x	7.86x	16.24x	2.61%	470B
MERCK & CO., INC.	101.52x	5.7x	24.22x	2.45%	344B
ROCHE HOLDING AG	18.95x	4.61x	11.45x	2.87%	336B
NOVARTIS AG	19.74x	5.16x	12.75x	3.1%	266B
ASTRAZENECA PLC	19.84x	4.13x	11.77x	2.15%	241B
AMGEN INC.	25.45x	6.66x	11.86x	2.5%	218B
GILEAD SCIENCES, INC.	-43.74x	6.39x	24.95x	2.28%	179B
Average	26.22x	6.50x	17.21x	2.3%	409.2B
Weighted average by Cap.	31.25x	7.60x	18.53x	1.96%